<DOC>
	<DOCNO>NCT00034528</DOCNO>
	<brief_summary>The purpose study find use low dose chemotherapy stem cell transplantation cure patient sickle cell anemia thalassemia cause few severe side effect conventional high dose chemotherapy transplantation .</brief_summary>
	<brief_title>Stem Cell Transplantation After Reduced-Dose Chemotherapy Patients With Sickle Cell Disease Thalassemia</brief_title>
	<detailed_description>Hemoglobinopathies , sickle cell disease thalassemia major , genetic disease associate significant morbidity premature death . Allogeneic bone marrow transplantation ( BMT ) potential cure severe hemoglobinopathy . Typical regimen use high dos chemotherapy chemo-radiotherapy ablate recipient hematopoiesis prevent graft rejection . The widespread use treatment limited toxicity , risk end-organ damage , donor availability . This study use nonmyeloablative regimen fludarabine busulfan attempt generate consistent engraftment donor hematopoietic stem cell patient severe hemoglobinopathy . G-CSF mobilization donor 's peripheral blood white blood cell precede donor apheresis . A nonmyeloablative conditioning regimen fludarabine busulfan administer patient prior allogeneic peripheral blood stem cell infusion . FK506 prednisone administer graft versus host disease ( GVHD ) prophylaxis . Patients evaluate engraftment , donor : host hematopoietic chimerism , toxicity , hemoglobinopathy .</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Hemoglobinopathies</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Hemoglobin SC Disease</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Inclusion criterion : All patient must : Have relate donor identical 6 human leukocyte antigen ( HLA ) locus ( A , B DR ) molecular type Have performance status 02 Give write informed consent Patients sickle cell disease 1 following : Acute chest syndrome require recurrent hospitalization exchange transfusion Nonhemorrhagic stroke central nervous system event last long 24 hour Recurrent vasoocclusive pain ( 2 episode per year ) recurrent priapism Sickle nephropathy ( moderate severe proteinuria glomerular filtration rate 3050 percent normal predict value ) Bilateral proliferative retinopathy major visual impairment least 1 eye Osteonecrosis multiple joint Patients thalassemia 1 following : Transfusion dependence , define transfusion requirement great equal 6 unit pack red blood cell past 12 month Iron overload , define serum ferritin great 500 mcg/L absence infection biopsyproven iron overload Presence 2 alloantibody red cell antigens Exclusion criterion : Pregnancy Acute hepatitis ( transaminases great 3 time normal value ) Cardiac ejection fraction le 30 percent Severe renal impairment ( glomerular filtration rate le 30 percent predict normal value ) Severe residual functional neurologic impairment ( hemiplegia alone ) Seropositivity human immunodeficiency virus ( HIV )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>